Reactions 1704, p179 - 2 Jun 2018 Haemorrhage secondary to access-site haematoma: case report In an observational single centre study of 41 patients, a patient [age and sex not stated] was described, who developed moderate haemorrhage secondary to access-site haematoma during treatment with heparin [unfractionated heparin; dosage not stated]. The patient, who had acute submassive pulmonary embolism and was planned to undergo ultrasound-assisted catheter-directed thrombolysis (USAT). The patient was in delayed USAT group and received USAT after 24 hours of diagnosis. The patient was administered IV heparin bolus dose of 80 IU/kg followed by infusion with a targeted activated partial thromboplastin time of 1.5 to 2 times the laboratory control. During and after the procedure, IV heparin was continued and was closely monitored in the cardiovascular ICU. However, the patient developed moderate haemorrhage secondary to access-site haematoma. The patient received treatment with 2 units of packed RBCs [time to reaction onset and outcome not stated]. Author comment: "[T]he goal of our study was to evaluate the association of early use of USAT (≤24 hours from diagnosis) vs delayed use of USAT (>24 hours from diagnosis)". "There were no deaths and no severe or life- threatening bleeding as defined by the GUSTO definition among any of the 41 patients . . . 1 patient in the delayed- USAT group), each related to access-site hematomas and requiring 2 units of packed red blood cells." Edla S, et al. Early Versus Delayed Use of Ultrasound-Assisted Catheter-Directed Thrombolysis in Patients with Acute Submassive Pulmonary Embolism. Journal of Invasive Cardiology 30: 157-162, No. 5, May 2018. Available from: URL: https:// www.ncbi.nlm.nih.gov/pubmed/29715164 - USA 803323616 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera